JAN (NYSE:JAN) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

JAN (NYSE:JAN) crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $28.01 and traded as low as $27.53. JAN shares last traded at $27.8070, with a volume of 1,896,947 shares trading hands.

Key Stories Impacting JAN

Here are the key news stories impacting JAN this week:

• Neutral Sentiment: No new JAN announcements, earnings releases, analyst updates, or other direct catalysts were included in the supplied articles.
• Negative Sentiment: The latest available quarterly results showed adjusted earnings of $0.05 per share, $0.18 below consensus estimates of $0.23. Although revenue of $216.5 million exceeded expectations and increased 45.4% year over year, the earnings miss may continue to weigh on investor sentiment.
• Positive Sentiment: JAN maintained fiscal 2026 earnings guidance of $0.95–$0.98 per share, broadly consistent with analysts’ expected full-year EPS of $0.97. Revenue growth remains a supportive factor.

Wall Street Analyst Weigh In

JAN has been the topic of a number of research reports. Weiss Ratings assumed coverage on shares of JAN in a report on Thursday, August 6th. They set a “hold (c-)” rating on the stock. Scotiabank raised their price target on shares of JAN from $31.00 to $33.00 and gave the company a “sector outperform” rating in a research report on Thursday, September 17th. Royal Bank Of Canada boosted their price target on shares of JAN from $30.00 to $34.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Huntington began coverage on JAN in a research report on Thursday, September 10th. They set an “outperform” rating and a $36.00 price objective on the stock. Finally, Zacks Research cut JAN from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 20th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $32.31.

JAN Stock Performance

The stock has a 50-day moving average price of $29.83 and a 200 day moving average price of $28.01.

JAN (NYSE:JAN) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.18). The company had revenue of $216.46 million for the quarter, compared to analysts’ expectations of $203.32 million. The business’s revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Research analysts predict that JAN will post 0.97 EPS for the current year.

JAN Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Friday, December 18th will be issued a dividend of $0.0475 per share. This represents a $0.57 annualized dividend and a yield of 2.0%. The ex-dividend date is Friday, December 18th.

Hedge Funds Weigh In On JAN

A number of institutional investors and hedge funds have recently modified their holdings of the company. Asset Management One Co. Ltd. increased its holdings in JAN by 1,764.5% in the third quarter. Asset Management One Co. Ltd. now owns 130,326 shares of the company’s stock valued at $3,862,000 after buying an additional 123,336 shares during the last quarter. Inspire Investing LLC purchased a new stake in JAN during the 3rd quarter worth about $484,000. Nisa Investment Advisors LLC purchased a new stake in JAN during the 3rd quarter worth about $27,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new stake in JAN during the 3rd quarter worth about $627,000. Finally, State of Alaska Department of Revenue boosted its position in shares of JAN by 57.6% during the 3rd quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company’s stock worth $1,082,000 after acquiring an additional 13,367 shares in the last quarter. Institutional investors and hedge funds own 6.27% of the company’s stock.

About JAN

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.